Remove tag patent
article thumbnail

Insurance Coverage for Psychedelic Therapy

Bill of Health

By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. Although this may be highly cost-effective (considering the cost of untreated PTSD), insurers may balk at the price tag.

FDA 201
article thumbnail

Building a Healthier Future with Real Wireless Power

HIT Consultant

Wirelessly powered devices like electronic price tags and asset trackers are changing the way retailers gather data and respond to evolving demand. He holds tens of granted patents globally related to Ossia’s Cota technology and beyond.